News & Resources

Novartis Receives EC Approval for New Indications for Cancer Drug Rydapt - by Drug Discovery & Development (9/20/17)

​

Drug Breakthrough for Mosquito Virus Outbreaks - by Griffith University (8/31/17)

​

'Unrealistic' serialization deadline? FDA offers one year grace period - by Flora Southey (7/4/17)

​

'Don't Underestimate Merck's vaccine business,' says CEO - by Dan Stanton (6/7/17)

​

Bayer, Novartis Gain New FDA Approvals for Cancer Drugs - by Ryan Bushey (5/1/17)

​

Teva's Austedo is first 'heavy hydrogen' drug to win US FDA approval - by Gareth MacDonald (4/12/17)

​

AstraZeneca ovarian cancer drug slows disease markedly in study - by Ben Hirschler (3/14/17)

​

GPCRs, Desirable Therapeutic Targets in Oncology - by Lee Schalop (1/25/17)

​

​

​

Hematology/Oncology Pharmacy Association - 

International Society for Pharmaceutical Engineering - 

​

Sanofi Expanding Fabrazyme Plant in MA - by Dan Stanton (1/31/18)

​

Lack of Sterility Assurance Leads to Recall of Numerous PharMEDium lots - by FDA MedWatch (1/3/18)

​

Merck KGaA to Transfer Tech for Vaccine Manufacturing site in Ghana - by Flora Southey (12/19/17)

​

Ansell to Acquire Isolator Glove Company gammaSUPPLIES -  Press Release Ansell/gS (11/27/17)

​

A Comprehensive Approach to USP <800> - by Gary Houchard et al. (11/21/17)

​

FDA Approves Roche Drug for Rare Blood Cancer - by Joanne Van Zuidam (11/07/17)

​

GSK Receives WHO Prequalification for Synflorix Pneumococcal Vaccine Four-Dose Vial - by GSK (10/19/17)

​

Biotech says its vaccines target and kill cancer cells, with fewer side effects - by Flora Southey (10/2/17)

​

​

Parenteral Drug Association - 

U.S. Pharmacopeial Convention - 

​